Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study
Status:
Terminated
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The primary objective was to study the clinical benefit with dalteparin sodium in
thromboprophylaxis in primary care medical subjects. The secondary objective was a
pharmacoeconomic evaluation of hromboprophylaxis with dalteparin sodium in primary care
medical subjects.